Author

Jing Fei

h-index 2 View on Semantic Scholar

We have 2 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy versus bevacizumab combined with chemotherapy in first-line treatment of driver gene-negative advanced non-squamous non-small cell lung cancer: a single-center retrospective study

For patients with driver gene-negative advanced non-squamous NSCLC, ICIs combined with chemotherapy are superior to bevacizumab combined with chemotherapy in terms of short-term efficacy and progression-free survival, with manageable but distinct adverse event profiles.

Wenqi Mo, Yin-zhen Li, Lu-Na Zhao et al. · Frontiers in Oncology · 0 citations

Review Open access Jul 2026

Nanoparticle‐Mediated Therapy for Glioma: Advances and Prospects

The design and characteristics of various nano‐platforms are focused on, and it is discussed in detail how they can drive multimodal synergistic therapies such as chemotherapy, radiotherapy and immunotherapy to improve the curative effect and overcome drug resistance.

Wen-Qian Jiang, Jing Fei, Rangrang Fan et al. · MedComm - Oncology · 1 citation